Top Hedge Fund News, Member Posts, Hedge Fund Daily Indices and more!

1yr ago Hedge Fund dealbreaker Views: 520

Biglaw means big bills -- and Shkreli doesn't have the money to pay them.

Things have really taken a turn for Martin Shkreli. The once successful pharmaceutical executive, hedge fund founder, and owner of a one-of-a-kind Wu-Tang Clan album earned the world’s hate and the nickname “pharma bro” after hiking up the price of the lifesaving drug Daraprim from $17.50 to $750 overnight.

Then came the lawsuits (numerous) and the jailtime (seven years), and now he’s so broke he can’t even pay his law firm’s legal fees.

Duane Morris, the firm that defended Shkreli against antitrust charges, recently asked a federal judge for permission to withdraw from representing their client, citing the fact that his outstanding bills haven’t been paid.

Reuters has the details on Shkreli’s continued fall from grace:

Duane Morris LLP said Shkreli’s former company Phoenixus AG agreed to cover his legal fees but has refused to pay the $2.04 million owed through March 31, after exhausting the limits of an insurance policy covering the fees in October.

In a filing in Manhattan federal court, Duane Morris also said Shkreli “has no assets” to pay its fees, and would not be harmed if it withdrew because the antitrust trial is over. The law firm said Shkreli did not oppose its withdrawal.

As Method Man once said, “Behind every fortune, there’s a crime.” Shkreli now seems to know that all too well — and he “has no assets” because of it. Ouch.

Martin Shkreli’s law firm has not been paid, seeks to withdraw [Reuters]

Staci Zaretsky is a senior editor at Above the Law, where she’s worked since 2011. She’d love to hear from you, so please feel free to email her with any tips, questions, comments, or critiques. You can follow her on Twitter or connect with her on LinkedIn.

For more of the latest in litigation, regulation, deals and financial services trends, sign up for Finance Docket, a partnership between Breaking Media publications Above the Law and Dealbreaker.


Today's Hedge Fund Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.